Winfree, Rebecca L. http://orcid.org/0000-0001-9798-2589
Nolan, Emma
Dumitrescu, Logan
Blennow, Kaj
Zetterberg, Henrik
Gifford, Katherine A.
Pechman, Kimberly R.
Seto, Mabel
Petyuk, Vladislav A.
Wang, Yanling
Schneider, Julie
Bennett, David A.
Jefferson, Angela L.
Hohman, Timothy J.
,
Funding for this research was provided by:
National Institute on Aging (RO1-AG059716, K01-AG049164, R21-AG059941, K24-AG046373, P20-AG068082, T32 AG058524, R01 AG034962)
Alzheimer's Association (IIRG-08-88733)
Article History
Received: 4 August 2023
Accepted: 11 April 2024
First Online: 18 May 2024
Declarations
:
: All protocols were approved by the Institutional Review Boards of all of the participating institutions including approval by the Vanderbilt University Medical Center Institutional Review Board. Informed written consent was obtained from all participants at each site.
: All authors have given consent to the publication of this manuscript.
: TH is a member of the scientific advisory board for Vivid Genomics (outside the work presented herein). HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).